---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-032511"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2024-07-05T23:59:59+00:00"
generated_at: "2026-05-31T23:16:54.669518+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Director resigns; Nasdaq confirms Gyre out of compliance on audit committee composition

## Summary
- Nassim Usman resigned from Board and Audit Committee, effective June 30, 2024, not due to any disagreements.
- On July 2, Nasdaq notified Gyre of non-compliance with Listing Rule 5605 (audit committee independence requirements).
- Cure period runs until earlier of next annual meeting or June 30, 2025; company is recruiting a new independent director.
- Company intends to reestablish compliance within cure period and avoid delisting.

## SEC filing metadata
- accession: 0001140361-24-032511
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2024-07-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000114036124032511/0001140361-24-032511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000114036124032511/ef20032140_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-032511
- JSON: https://secwatch.observer/filing/0001140361-24-032511.json
- Plain text: https://secwatch.observer/filing/0001140361-24-032511.txt

## Key facts
- Executive change
  Nassim Usman resigned as Director at GYRE THERAPEUTICS, INC..
  - Action: resigned
  - Role: Director
  source text: On June 28, 2024, Nassim Usman, Ph.D. informed the Company that he intended to resign from the Board, effective as of June 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124105/000114036124032511/0001140361-24-032511-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.